Description
A CFTR potentiator; increases the forskolin-induced CFTR-mediated epithelial current in cells expressing the G551D missense mutation by ~4-fold (EC50 = 100 nM); increases chloride secretion in cultured human cystic fibrosis bronchial epithelial cells carrying the G551D mutation on one allele and the common ΔF508 processing mutation on the other allele; binds CFTR directly and leads to CFTR channel opening via an ATP-independent mechanism
Formal name: N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide
Synonyms: VX 770
Molecular weight: 392.5
CAS: 873054-44-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Ion Channel Modulation|Activators||Research Area|Immunology & Inflammation|Pulmonary Diseases|Cystic Fibrosis